Synthesis and Antimalarial Evaluation of Halogenated Analogues of Thiaplakortone A

Mar Drugs. 2023 May 22;21(5):317. doi: 10.3390/md21050317.

Abstract

The incorporation of bromine, iodine or fluorine into the tricyclic core structure of thiaplakortone A (1), a potent antimalarial marine natural product, is reported. Although yields were low, it was possible to synthesise a small nine-membered library using the previously synthesised Boc-protected thiaplakortone A (2) as a scaffold for late-stage functionalisation. The new thiaplakortone A analogues (3-11) were generated using N-bromosuccinimide, N-iodosuccinimide or a Diversinate™ reagent. The chemical structures of all new analogues were fully characterised by 1D/2D NMR, UV, IR and MS data analyses. All compounds were evaluated for their antimalarial activity against Plasmodium falciparum 3D7 (drug-sensitive) and Dd2 (drug-resistant) strains. Incorporation of halogens at positions 2 and 7 of the thiaplakortone A scaffold was shown to reduce antimalarial activity compared to the natural product. Of the new compounds, the mono-brominated analogue (compound 5) displayed the best antimalarial activity with IC50 values of 0.559 and 0.058 μM against P. falciparum 3D7 and Dd2, respectively, with minimal toxicity against a human cell line (HEK293) observed at 80 μM. Of note, the majority of the halogenated compounds showed greater efficacy against the P. falciparum drug-resistant strain.

Keywords: Diversinate™; N-bromosuccinimide; N-iodosuccinimide; Plasmodium; biodiscovery; halogenation; late-stage functionalization; library; malaria; natural product; sulfinate; thiaplakortone A.

MeSH terms

  • Antimalarials* / chemistry
  • Antimalarials* / pharmacology
  • Biological Products* / chemistry
  • HEK293 Cells
  • Humans
  • Malaria, Falciparum* / drug therapy
  • Plasmodium falciparum
  • Triazines / chemistry

Substances

  • Antimalarials
  • thiaplakortone A
  • Triazines
  • Biological Products